vTv Therapeutics Inc.
VTVT
$33.45
$0.662.01%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 75.68% | 112.05% | -46.11% | -28.21% | 3.08% |
| Total Depreciation and Amortization | -89.29% | -89.47% | -82.02% | -60.00% | -37.78% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 422.13% | 219.42% | 87.37% | 40.05% | -4,328.00% |
| Change in Net Operating Assets | -997.82% | -266.80% | 134.79% | 234.08% | 16.53% |
| Cash from Operations | 23.90% | 55.98% | 0.21% | 10.97% | -0.98% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -105.24% | 86.47% | 100.00% |
| Issuance of Common Stock | 3,034.43% | 3,046.24% | 46.77% | 46.76% | -95.09% |
| Repurchase of Common Stock | 100.00% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 3,100.45% | 3,044.17% | 47.21% | 48.61% | -95.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 409.74% | 416.22% | 91.16% | 70.80% | -159.54% |